Product Code: GVR-4-68039-991-4
Biopharma Plastic Market Growth & Trendss
The global biopharma plastic market size is anticipated to reach USD 11,290.12 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.95% from 2025 to 2030. The rise in global healthcare expenditure for research & development of biopharma plastics is anticipated to drive the market. In addition, the rising demand for biopharmaceuticals, owing to the increasing cases of cancerous patients across the globe, is anticipated to propel the demand for biopharma plastics.
Plastics are widely used in this industry due to their versatility, durability, and cost-effectiveness. The use of plastics in biopharma applications includes packaging and delivery systems, laboratory equipment, diagnostic devices, and drug delivery devices.
The global biopharma plastics industry is expected to experience significant growth in the coming years. This growth is driven by factors such as the increasing demand for biopharmaceuticals, the growing prevalence of chronic diseases, and the rise in healthcare expenditure. Additionally, the need for more advanced and innovative packaging and delivery systems for biopharmaceuticals is also expected to drive market growth.
Moreover, the biopharma industry is increasingly focused on sustainability and reducing its environmental footprint. This has led to a growing demand for biodegradable and recyclable plastics that can be used in biopharma applications. Companies are investing in research and development to create more sustainable plastics that meet the needs of the biopharma industry.
The biopharma industry is characterized by a high level of research and development activity, as companies invest in developing new drugs and delivery systems. This is driving demand for specialized biopharma plastics that can support this research and development, such as laboratory equipment and diagnostic devices.
Biopharma Plastic Market Report Highlights:
- Asia Pacific accounted for the largest revenue share of 30.92% of the global biopharma plastics industry in 2024 and is expected to continue its dominance over the forecast period. This can be attributed to the increasing R&D and rising demand for high-quality biopharma plastic devices and components from the oncology industry across the region
- Based on application segmentation, syringes accounted for a maximum share of 20.55% in 2024 and are likely to remain dominant over the forecast period. This is attributed to its compatibility with a wide range of biopharmaceutical products, including vaccines, antibiotics, insulin, and other injectable drugs. Moreover, the increasing demand for prefilled syringes to enhance surgical procedures is likely to boost the demand for biopharma plastics for manufacturing syringes
- In the polymer type segmentation, polyvinyl chloride (PVC) dominated the market in 2024, with a market share of 21.56%. This is attributed to the various properties of PVC including flexibility, compatibility, and durability, making it suitable for manufacturing depth filters for stem cell extraction. Due to its versatility, PVC can be easily molded into different shapes and sizes, making it ideal for various applications in the biopharma industry
- In April 2023, PSG Group International, one of the leading global pump, metering, and dispensing-solution company, launched a new biotech brand with the name 'PSG(R) Biotech for life science and Biopharma'.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.2 Market Definitions
- 1.3 Information Procurement
- 1.3.1 Information analysis
- 1.3.2 Market formulation & data visualization
- 1.3.3 Data validation & publishing
- 1.4 Research Scope and Assumptions
- 1.4.1 List to Data Sources
Chapter 2 Executive Summary
- 2.1 Market Snapshot 2022
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape Snapshot
Chapter 3 Biopharma Plastics Market: Variables and Trends
- 3.1 Market Lineage Outlook
- 3.1.1 Global Plastics Market
- 3.2 Biopharma Plastics Market- Penetration & Growth Prospect Mapping
- 3.3 Industry Value Chain Analysis
- 3.3.1 Raw Material trends
- 3.3.1.1 Propylene
- 3.3.1.2 Ethylene Terephthalate
- 3.3.1.3 Ethylene
- 3.3.1.4 VinYL Chloride
- 3.4 Technology Overview
- 3.4.1 Biopharma Plastics Market- Patent Analysis
- 3.5 Regulatory Framework
- 3.5.1 Standard & Compliances
- 3.5.1.1 Polyethylene (Pe)
- 3.5.2 Safety
- 3.5.2.1 Polyethylene (Pe)
- 3.5.2.2 Polypropylene (Pp)
- 3.5.2.3 Acrylonitrile Butadiene Styrene (Abs)
- 3.5.2.4 Polyvinyl Chloride
- 3.6 Market Dynamics
- 3.6.1 Market Driver Impact Analysis
- 3.6.1.1 Rise in global healthcare expeNditure
- 3.6.1.2 Increasing cases of cancerous patients across the globe
- 3.6.2 Market Restraint Impact Analysis
- 3.6.2.1 Volatile Raw Material Prices
- 3.6.3 Market Challenges analysis
- 3.6.4 Market Opportunity analysis
- 3.7 Impact of Russia & Ukraine Implication on Biopharma Plastics Market
- 3.8 Impact of COVID-19 on Biopharma Plastics Market
- 3.9 Industry Analysis Tools
- 3.9.1 porter's analysis
- 3.9.2 Macroeconomic Analysis
Chapter 4 Biopharma Plastics Market: Polymer Type Estimates & Trend Analysis
- 4.1 Polymer Type Movement Analysis & Market Share, 2022 & 2030
- 4.2 Polymer Type Movement Analysis & Market Share, 2022 & 2030
- 4.3 Biopharma Plastics Market Estimates & Forecast, By Polymer Type (Kilotons) (USD Million)
- 4.3.1 Polyethylene (PE)
- 4.3.2 Polypropylene (PP)
- 4.3.3 Acrylonitrile Butadiene Styrene (ABS)
- 4.3.4 Polyethylene Terephthalate (PET)
- 4.3.5 Polyvinyl Chloride (PVC)
- 4.3.6 Polytetrafluoroethylene (PTFE)
- 4.3.7 Polycarbonate (PC)
- 4.3.8 Others
Chapter 5 Biopharma Plastics Market: Application Estimates & Trend Analysis
- 5.1 Application Movement Analysis & Market Share, 2022 & 2030
- 5.2 Application Movement Analysis & Market Share, 2022 & 2030
- 5.3 Biopharma Plastics Market Estimates & Forecast, By Application (Kilotons) (USD Million)
- 5.3.1 Protective Wear
- 5.3.2 Containers
- 5.3.3 Bioreactor Bags
- 5.3.4 Syringes
- 5.3.5 Depth Filters
- 5.3.6 Disposable Medical Connectors
- 5.3.7 Others
Chapter 6 Biopharma Plastics Market: Regional Estimates & Trend Analysis
- 6.1 Biopharma Plastics Market: Regional Outlook
- 6.2 North America
- 6.2.1 North america Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (Kilotons) (USD Million)
- 6.2.2 U.S.
- 6.2.2.1 U.S. Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.2.3 Canada
- 6.2.3.1 Canada Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.2.4 Mexico
- 6.2.4.1 Mexico Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.3 Europe
- 6.3.1 Europe Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (Kilotons) (USD Million)
- 6.3.2 Germany
- 6.3.2.1 Germany Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.3.3 France
- 6.3.3.1 France Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.3.4 UK
- 6.3.4.1 UK Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.3.5 Italy
- 6.3.5.1 Italy Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.4 Asia Pacific
- 6.4.1 Asia Pacific Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kiloTons) (USD Million)
- 6.4.2 China
- 6.4.2.1 china Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (Kilotons) (USD Million)
- 6.4.3 India
- 6.4.3.1 india Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (Kilotons) (USD Million)
- 6.4.4 Japan
- 6.4.4.1 Japan Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (Kilotons) (USD Million)
- 6.5 Central & South America
- 6.5.1 Central & South America Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (Kilotons) (USD Million)
- 6.5.2 Brazil
- 6.5.2.1 Brazil Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.5.3 Argentina
- 6.5.3.1 Argentina Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.6 Middle East & Africa
- 6.6.1 Middle East & Africa Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (Kilotons) (USD Million)
- 6.6.2 GCC Countries
- 6.6.2.1 GCC Countries Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
- 6.6.3 South Africa
- 6.6.3.1 south africa Biopharma Plastics Market estimates & Forecasts, 2019 - 2030 (kilotons) (USD Million)
Chapter 7 Biopharma Plastics Market - Competitive Landscape
- 7.1 Key Market Participants
- 7.1.1 BASF SE
- 7.1.2 LyondellBasell Industries Holdings B.V.
- 7.1.3 SABIC
- 7.1.4 LG Chem
- 7.1.5 Toray Industries, Inc.
- 7.1.6 Solvay
- 7.1.7 Dow, Inc.
- 7.1.8 DuPont de Nemours, Inc.
- 7.1.9 Saint-Gobain Performance Plastics
- 7.1.10 Tekni-Plex
- 7.1.11 Chevron Phillips Chemical Co., LLC
- 7.1.12 Exxon Mobil Corporation
- 7.1.13 Formosa Plastics Corporation
- 7.1.14 Covestro AG
- 7.1.15 TEIJIN LIMITED
- 7.1.16 Mitsui & Co. Plastics Ltd.
- 7.1.17 INEOS Group
- 7.1.18 CHIMEI
- 7.2 Recent Developments & Impact Analysis, By Key Market Participants
- 7.3 Company Categorization
- 7.4 Vendor Landscape
- 7.4.1 List of Key Distributors & Channel Partners
- 7.4.2 List of Key Potential Customers/End-users
- 7.5 Participant's Overview
- 7.6 Financial Performance
- 7.7 Product Benchmarking
- 7.8 Company Heat Map Analysis
- 7.9 Strategy Mapping
- 7.9.1 Expansion
- 7.9.2 Mergers & Acquisition
- 7.9.3 Collaboration
- 7.9.4 New Application Launches
- 7.9.5 Research & Development